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Abstract
Prokaryotic and eukaryotic organisms respond to various stresses with the production of
heat shock proteins (HSPs).  HSPs are molecular chaperones that bind to unfolded proteins and
inhibit their aggregation as well as maintaining their solubility until they can be refolded to their
original conformation.  Stress-inducible hsp gene transcription is mediated by the heat shock
element (HSE), which interacts with heat shock transcription factor (HSF).  In this study, we
examined the effect of KNK437 (N-formyl-3,4-methylenedioxy-benzylidene-g-butyrolactam), a
benzylidene lactam compound, on heat shock, sodium arsenite, cadmium chloride and
herbimycin A-induced hsp gene expression in Xenopus laevis A6 kidney epithelial cells.  In
studies limited to mammalian cultured cells, KNK437 has been shown to inhibit HSE-HSF1
binding activity and stress-induced hsp gene expression.  In the present study, western and
northern blot analysis revealed that exposure of A6 cells to heat shock, sodium arsenite,
cadmium chloride and herbimycin A induced the accumulation of HSP30 protein and hsp30
mRNA, respectively.  Western blot analysis also determined that exposure of A6 cells to heat
shock, sodium arsenite, cadmium chloride and herbimycin A induced the accumulation of
HSP70 protein.  Pre-treatment of A6 cells with 100 µM KNK437 inhibited stress-induced hsp30
mRNA as well as HSP30 and HSP70 protein accumulation.  Immunocytochemistry and confocal
microscopy were used to confirm the results gained from western blot analysis as well as
determine the localization of HSP30 accumulation in A6 cells.  A 2 h heat shock at 33°C resulted
in the accumulation of HSP30 in the mostly in the cytoplasm with a small amount in the nucleus.
Heat shock at 35°C resulted in substantial HSP30 accumulation in the nucleus.  This is in
contrast with A6 cells treated for 14 h with 10 µM sodium arsenite, 100 µM cadmium chloride
and 1 µg/mL herbimycin A, where HSP30 accumulation was found only in the cytoplasm and
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not in the nucleus.  A 6 h pre-treatment with 100 µM KNK437 completely inhibited the
accumulation of HSP30 in A6 cells heat shocked at 33 or 35°C as well as cells treated with 1
µg/mL herbimycin A.  The same pre-treatment with KNK437 resulted in a 97-100% decrease in
HSP30 accumulation in A6 cells treated with 10 µM sodium arsenite or 100 µM cadmium
chloride.  These results show that KNK437 is effective at inhibiting both heat shock and
chemical induced hsp gene expression in amphibian cells.
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1  Introduction
Throughout evolution, it has been imperative that organisms, both prokaryotic and
eukaryotic, have the ability to survive and adapt to thermal stress.  Thermal stress leads to a
complex regulation of gene expression and biochemical adaptive responses (Lindquist, 1986).
Within the category of altered gene expression, there is a variation in the pattern of expression of
stress inducible proteins known as the heat shock proteins (HSPs) (Lindquist & Craig, 1988;
Feige et al., 1996).
1.1  Heat Shock Proteins
Ritossa and colleagues were the first to discover HSPs in the salivary glands of Drosophila
in 1962. The heat shock family is composed of six major families, HSP100, HSP90, HSP70,
HSP60, HSP40 and the small HSP family (Katschinski, 2004).  Certain HSPs including HSP60,
HSC70 and HSP90 are present constitutively in the cell and function in protein folding, assembly
and transport (Georgopoulos and Welch, 1993), while others such as HSP70 are stress inducible
(Lisowska et al., 1994; Feige et al., 1996).  HSPs act as molecular chaperones, which bind to
damaged and denatured proteins in order to prevent their aggregation and misfolding during
cellular stress.  The exact method that cells use to sense stress is largely unknown, however it is
thought that damaged protein is likely involved in the sensing mechanism (Agashe & Hartl,
2000).
1.2  The heat shock response
In addition to heat, HSPs are synthesized in response to many other stressors.
Environmental stress including heavy metals, arsenites, ethanol and hydrogen peroxide can
induce HSP accumulation as well as pathophysiological states such as aging, damage by oxygen
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radicals and bacterial and viral infection.  It has also been shown that non-stressful conditions
such as development and the presence of growth factors and can induce hsp gene expression.
The quantity of HSPs expressed varies with the inducer or environment that the cells are
subjected to (Lindquist and Craig, 1988; Parsell and Lindquist, 1993; Morimoto et al., 1994;
Feige et al., 1996).
HSP gene regulation occurs primarily at the transcriptional level, although control at the
posttranscriptional and translational levels has been described (Lis and Wu, 1993; Morimoto,
1993).  Heat shock transcription factors (HSFs) are involved in the activation of stress-inducible
hsp gene expression (Morimoto et al., 1994).  Only one hsf gene has been isolated from
Saccharomyces cerevisiae (Sorger & Pelham, 1988; Wiederrecht et al., 1988) and from
Drosophila melanogaster (Clos et al., 1990).  However, multiple members of the HSF family
have been found in vertebrates (HSF1-4) (Wu, 1995; Nover et al., 1996; Morano & Thiele, 1999;
Nakai, 1999).  HSF1 is stress inducible and is homologous to the single HSF gene found in yeast
and fly.  HSF2 does not appear to be stress inducible, but instead is activated during
developmental processes.  HSF3 and HSF4 have only been characterized in the avian and
mammalian systems, respectively (Nakai, 1999).  The expression of HSF3 in chicken is limited
to undifferentiated cells and embryonic tissue.  HSF1 and HSF3 seem to have redundant roles in
undifferentiated cells, however, HSF3 is expressed under heat shock conditions in the blood cells
of chicken embryos, where HSF1 is lacking (Shabtay & Arad, 2006).  HSF4 is constitutively
active as a trimer as it lacks a leucine zipper-like domain (HR-C) which suppresses trimer
formation.  Information gained from HSF4 mouse knockouts determined that HSF4 is required
for cell growth and differentiation of the eye lens during development (Fujimoto et al., 2004).
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All HSF proteins have very divergent amino acid sequences with the exception of two
well-conserved domains; the N-terminal DNA binding domain and the trimerization or activation
domain.  Adjacent to the DNA binding domain there are hydrophobic heptad repeats (HR-A/B)
that act as leucine zippers.   There is also an additional hydrophobic heptad region (HR-C)
located near the C-terminus (Lis and Wu, 1993; Morimoto, 1993) (Figure 1).  Both HSF1 and
HSF2 genes have been found in Xenopus laevis (Stump et al., 1995; Hilgarth et al., 2004).
With the exception of yeast, HSFs are found in the cell in a monomeric state and have no
DNA binding ability until the cell is stressed.  There are several steps in the stress inducible
HSF1 regulatory pathway.  The first is the stress-induced conversion of HSF monomers to
homotrimers, which allows the HSF1 trimers to bind to a conserved 15 bp region of the heat
shock element (HSE) found upstream of heat shock protein genes (Figure 2).  The second step
involves a conformational change to the transcriptional activation domain (Westwood et al.,
1991; Westwood and Wu, 1993).  Removal of the stressor leads to the final stage of the HSF1
regulatory pathway called deactivation.  HSF1 trimers return to a monomeric state and no longer
activate transcription of hsp genes.  If the cells are exposed to the stressor for a long period of
time, HSF1 may lose its binding and transcriptional abilities before removal of the stressor.  This
process is called attenuation (Clos et al., 1990; Rabindran et al., 1991; Nakai & Morimoto,
1993).
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Figure 1.  Functional organization of human HSF1.  N and C represent the amino and carboxy
terminals respectively.  Adapted from Locke and Noble (2002).  
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Figure 2.  HSF Activation Model.  Adapted from Locke and Noble (2002).  
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1.3  Chemical inducers of hsp gene expression
In addition to heat shock, chemical stressors such as sodium arsenite, cadmium chloride
and herbimycin A can induce the expression of hsp genes.  Arsenic is a known human
carcinogen that is most commonly encountered in drinking water but is also found in the metal
smelting and glass making industries.  Arsenic exposure in humans results in increased risk for
diabetes, spontaneous abortions, gangrene, atherosclerosis and ischemic heart disease (Chen et
al., 1996; Nickson et al., 1998; Gebel, 2001; Hughes, 2002; Tseng et al., 2002).  Examination of
cells exposed to arsenic has revealed many side effects including apoptosis, malignant cell
transformation, cell cycle arrest, induction of the stress response, inhibition of cell proliferation
and cytoskeletal injury (Chou 1989, Li & Chou, 1992; Liu et al., 2001; Bode & Dong, 2002).
While many side effects of arsenic exposure are known, the exact mechanism of toxicity to the
cells is not.  It has been suggested that changes to DNA repair and methylation or the induction
of reactive oxygen species may be involved in this mechanism which may be involved in the
induction of heat shock proteins (Harris & Shi, 2003; Shi et al., 2004).  Sodium arsenite is a well
known inducer of the heat shock response  (Darasch et al., 1998; Kim et al., 2001).
The kidney is the organ that is most strongly affected by cadmium toxicity (Faurskov &
Bjerregaard, 2002).  There is also evidence that cadmium increases the levels of reactive oxygen
species in certain cell types (Thevenod & Friedman, 1999; Yang et al., 2004; Kim et al., 2005).
An increase in reactive oxygen species has been shown to induce a heat shock response as
proteins that are oxidatively damaged will bind HSPs and therefore release HSF1 (McDuffee et
al., 1997).  Cadmium exposure was also found to lead to apoptosis through the unfolded protein
response (Yokouchi et al., 2007).  Treatments with cadmium chloride have been shown to cause
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the induction of heat-shock proteins in mammalian and amphibian cells (Kim et al., 2001;
Gauley & Heikkila, 2006).
Herbimycin A is a benzoquinoid ansamycin antibiotic that was originally isolated as a
potential herbicide and is now known to inhibit protein tyrosine kinase activity (Uehara et al.,
1989; Fukazawa et al., 1990).  Herbimycin A has been shown to induce hsp gene expression in
mammalian, avian and amphibian cells (Caltabiano et al., 1986, Murakami et al., 1991; Levinson
et al., 1980, Briant et al., 1997).  Interestingly, treatment of mammalian cells with herbimycin A
did not result in any detectable negative effects to the cells such as protein insolubility, changes
to the intermediate filament cytoskeleton or interference with protein folding and assembly as
seen previously with heat shock and chemical treatments (Hegde et al., 1995).
1.4  Small heat shock proteins
1.4.1  Structure of sHSPs
The sHSP family of proteins is not well conserved with the exception of an 80-100 amino
acid domain that shares sequence homology with the eye lens protein α-crystallin.  This domain
is therefore called the α-crystallin domain and is located at the C-terminal end (Ingolia et al.,
1982).  The sequence similarity of this region ranges from 20% in distantly related members of
the sHSP family to 60% in closely related mammalian family members (Berengian et al., 1999).
Although the sequence of the α-crystallin domain is variable, the domain forms a compact β-
sheet sandwich which is well conserved (Kim et al., 1998; van Montfort et al., 2001 a,b).
Following the C-terminal, there is a short, flexible, highly polar tail called the C-terminal tail/
extension (Carver et al., 1992; 1995; Ehrnsperger et al., 1997), which is though to be involved in
maintaining the solubility of the sHSP (Fernando & Heikkila, 2000) as well as the formation of
oligomeric complexes (Fernando & Heikkila, 2002).  The N-terminal end is hydrophobic and is
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not well conserved in sequence or length (Arrigo & Landry, 1994; MacRae, 2000), however a
WDPF domain is found at the very N-terminal end of some sHSPs.  The WDPF domain has been
shown to maintain the oligomer structure and chaperone activity of HSP27 (Theriault et al.,
2004).  The different molecular sizes of the sHSP family members can be explained by the
differing lengths of variable sites between the WDPF domain and the α-crystallin domain as well
as the variable length of the C-terminal tail (Gusev et al., 2002).  SHSP monomers range in size
from 12 to 43 kDa (MacRae, 2000; van Montfort, 2001a) and form highly polymeric structures
which have been shown to be necessary for substrate binding and chaperone function (Arrigo
and Landry, 1994).  The size of sHSP polymers range from 100kDa to 10Ma when cells are
undergoing stress (Arrigo & Landry, 1994; Fernando et al., 2003; Azzoni et al., 2004).  The
crystal structure of many sHSP polymers appears to be globular or ring-like structures with a
central cavity (Sun & MacRae, 2005).
1.4.2  Expression of sHSPs
SHSPs have been described in all eukaryotes (de Jong et al., 1993, 1998; Kappe et al., 2001)
and prokaryotes (Kappe et al., 2002) examined.  The number of genes that encode sHSPs
depends on the organism.  There have been ten discovered in human; four in Drosophila, more
than sixteen in Xenopus laevis and over thirty in plants (Parsell and Lindquist, 1993; Arrigo and
Landry, 1994; Tam and Heikkila, 1995; Ohan and Heikkila, 1995; Helbing et al., 1996; Heikkila
et al., 1997b, Michaud et al., 2002).  Expression of sHSPs depends on growth conditions,
developmental state as well as the oncogenic status of the cell (Haslbeck, 2002).  Comparing the
expression of sHSP to other HSPs in the cell in response to heat shock and other stressors has
demonstrated that sHSPs are some of the most strongly induced HSPs (Arrigo & Landry, 1994;
Haslbeck, 2002).
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1.4.3  Function of sHSPs
1.4.3.1  Chaperone activity
It has been well documented that sHSPs act as molecular chaperones in vitro since they can
bind to non-native or unfolded proteins and prevent them from aggregating (Haslbeck et al.,
1999; Horwitz, 1992; Jakob et al., 1993; Ehrnsperger et al., 1998; Derham & Harding, 1999; Lee
& Vierling, 2000; Haslbeck, 2002).  In vitro sHSP chaperone activity depends on
oligomerization and it has been hypothesized that the same is true for sHSPs in vivo (MacRae,
2000; Narberhaus, 2002).  It is thought that when the sHSP chaperones are exposed to stress,
they dissociate into smaller subunits thereby exposing their hydrophobic surface (Raman et al.,
1995; Lee et al., 1997).  This hydrophobic surface is then accessible to the substrate (van
Montfort et al., 2001a; Zantema et al., 1992; Haslbeck et al., 1999).
While sHSPs are able to bind non-native proteins and keep them in a soluble, inactive state,
they are not directly involved in the refolding process.  When the stress has been removed, the
sHSPs bring the unfolded proteins to ATP dependant HSPs such as HSP70, which are
responsible for the refolding process (Fernando and Heikkila, 2000).  Phosphorylation of serine
residues of animal sHSPs causes oligomer dissociation (MacRae, 2000; Kato et al., 1994, 2002;
Fernando et al., 2003), lowering in vitro chaperone activity (Rogalla et al., 1999; Ito et al., 2001;
Fernando et al., 2003).
1.4.3.2  Actin capping/decapping
Cellular stress leads to modifications of the cytoskeleton as well as the rapid production of
heat shock proteins.  The cytoskeleton is comprised of three types of protein fibres:
microtubules, microfilaments and intermediate filaments.  SHSPs preserve the condition of
microfilaments and intermediate filaments (Liang and MacRae, 1997).  Microfilaments are
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involved in maintaining the shape of the cell, motility, endocytosis, exocytosis, cytokinesis, cell-
cell/ cell-substrate interactions and signal transduction. G-actin refers to the soluble pool of
globular monomeric actin, which polymerizes into F-actin, also known as microfilaments.  It is
unknown whether the interaction between F-actin and sHSPs is direct or indirect.  However, it
has been proposed that phosphorylated sHSPs in a group of small oligomers coat the
microfilaments promoting their recovery and preventing actin severing proteins activated during
the stress response from attacking the microfilaments.  Non-phosphorylated sHSP monomers
may cap the growing end of the actin filament and play a role in regulating microfilament
assembly (Mournier and Arrigo, 2002).
1.4.3.3  Apoptosis
SHSPs are overexpressed in malignant tumours and have been implicated in the growth
of tumour cells and are able to confer cytostatic resistance (Kang et al., 2004; Rocchi et al.,
2004).  The protective effect of sHSPs is partly due to chaperone activity whereby proteins are
protected from aggregation (Ehrnsperger et al., 1997; Lee et al., 1997).  However, sHSPs are
known to bind directly to certain components of the mitochondrial apoptosis pathway both
upstream and downstream and therefore can prevent apoptosis in response to cell stress (Arrigo,
2005; Kamradt et al., 2005).  Protection of the actin cytoskeleton is also a proposed method of
sHSP mediated inhibition of apoptosis (Lavoie et al., 1993; Huot et al., 1996).
HSP27 and αB-crystallins are well studied members of the human sHSP family and have
been shown to have an anti-apoptotic effect in response to various stressors.  They are also
involved in regulating metastatic potential and tumour progression (Arrigo, 2005; Sun &
MacRae 2005).  HSP27 in rat olfactory neurons determine the balance between differentiation
and apoptosis.  Overexpression of HSP27 leads to an increase in the rate of differentiation and a
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decrease in the rate of cell death, whereas underexpression leads to a complete loss of
differentiation and a huge increase of apoptotic cells (Mehlen et al., 1999).
1.4.3.4  Cellular differentiation
Since the discovery of the involvement of increased Drosophila HSP27 protein
expression in ecdysterone mediated differentiation of imaginal disks (Pauli et al., 1990), many
studies have examined the involvement of various sHSPs in differentiation.  In general it has
been found that at least one sHSP was induced during the process of differentiation of a
particular type of cell (Arrigo, 2005).  Enhanced expression of HSP27 has been implicated in the
differentiation processes of muscle cells (Benjamin et al., 1997); neurons (Mehlen et al., 1999),
chondrocytes (Favet et al., 2001) and cardiomyocytes (Davidson & Morange, 2000).  Mehlen
and colleagues (1997) have also found that increased expression of HSP27 during differentiation
is usually concurrent with an increase in phosphorylation.  Interestingly, in vivo studies have
suggested that HSP27 is probably not involved in all differentiation processes (Duverger et al.,
2004).
1.4.3.5  Redox reactions
Reactive oxygen species (ROS) are produced under normal physiological conditions in all
aerobic organisms.  ROS can lead to oxidative damage without the activity of various important
enzymes and antioxidants naturally present in the cell (Papp et al., 2003).  Various sHSPs and
HSP70 act as cytoplasmic antioxidants to protect proteins from oxidative damage by covering
the sites sensitive to damage by ROS.  In the case that the oxidative damage is too strong for the
HSPs to handle, they hold the denatured proteins until they are refolded or denatured (Papp et
al., 2003).  Oxidative stress leads to induction of HSPs which is largely mediated by the
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oxidatively damaged proteins themselves (McDuffee et al., 1997) which activates HSF1
(Morimoto, 1999).
1.4.3.6  Heat shock proteins and disease
Several common neurodegenerative conditions such as Alzheimer’s, Parkinson’s and
Huntington’s are associated with the aggregation of improperly folded proteins forming high-
ordered insoluble fibrils (Reviewed in Selkoe, 2004; Landles & Bates, 2004).  The above
mentioned diseases have mutations in one or more proteins causing changes in protein
conformation and leading to improperly functioning proteins that are prone to aggregation
because of their exposed hydrophobic surfaces. Chaperones have evolved to block these
hydrophobic surfaces as well as maintaining the cellular pool of proteins in a properly folded
state (Hartl & Hayer-Hartl, 2002).  The ubiquitin-proteasome system is also present to target
improperly folded proteins for degradation (Weissman, 2001).
1.5   Xenopus laevis as a model organism
The South African clawed frog, Xenopus laevis has been used extensively as a model for
amphibian development.  This aquatic frog is inexpensively and easily cared for in the
laboratory.  The eggs are large and suitable for microinjection and the embryos develop quickly
(Sive et al., 2000).  Xenopus laevis is also an excellent bioindicator for genotoxic stress.
Metallic pollution is an escalating problem in the aquatic environment and amphibians have been
used to investigate the effects various chemicals and heavy metals have on the viability and
development (Zoll et al., 1990; Djomo et al., 2000; Mouchet et al., 2005a,; 2006).
A Xenopus laevis A6 kidney epithelial cultured cell line, which originated in renal uniferous
tubules of adult Xenopus (Rafferty & Sherwin, 1969), has been used in numerous studies.  The
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A6 cell line is hardy and quick growing as the doubling time averages at 22 hours.  The rate of
cell division remains logarithmic before confluency and cells continue to divide after confluency
is reached.  This is in contrast with a decreased growth rate caused by contact inhibition that is
sometimes seen in other cell lines (Rafferty, 1968).  Hsp30 gene expression has been previously
described in Xenopus laevis A6 kidney epithelial cells and embryos (Ali et al., 1993; Tam and
Heikkila, 1995; Lang et al., 1999; Heikkila, 2003; Heikkila, 2004; Gellalchew and Heikkila,
2005).
1.6  SHSP family members
1.6.1  HSP27
HSP27 is a heat shock inducible sHSP that is present constitutively in many cell types and
tissues (Arrigo & Landry, 1994).  HSP27 is involved in cell growth/differentiation (Mehlen et
al., 1997; Arrigo & Préville, 1999), increased resistance to cellular oxidation (Arrigo, 2001) and
is a predictor of a negative response to treatment in patients with breast cancer (Love & King,
1994), and prostate cancer (Rocchi et al., 2004).  Also, HSP27 is a negative regulator of
apoptosis and is most likely important for general development as HSP27 knockout mice do not
survive (Brar et al., 1999, Garrido, 2002).
1.6.1.1  HSP27 in Xenopus laevis
HSP27 has recently been discovered in Xenopus laevis and is a homolog of human HSP27
(Tuttle et al., 2007).  Interestingly, Xenopus HSP27 has only a 19% identity with Xenopus
HSP30C, with the highest similarity in the alpha crystallin domain.  In the desert topminnow,
HSP27 is similar to mammalian and avian HSP27 rather than to HSP30 (Norris et al., 1997).
Similarly, Xenopus HSP27 grouped with HSP27 family members in different species such as
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chicken HSP24, human HSP27, mouse HSP25 and topminnow HSP27 rather than with Xenopus
HSP30 (Tuttle et al., 2007).  Constitutive levels of hsp27 mRNA were found in Xenopus laevis
developing embryos beginning at the early tailbud.  Following heat shock, increased hsp27
mRNA levels continued to increase.  This is in contrast with hsp30 mRNA which is heat
inducible but not constitutively expressed.  Recombinant HSP27 forms large multimeric
complexes which inhibit thermal aggregation (Tuttle et al., 2007).
1.6.2  HSP30
In addition to Xenopus, hsp30 genes have also been reported in other amphibians, fish and
chicken (Mulligan-Tuttle & Heikkila, 2007; Norris et al., 1997; Katoh et al., 2004).  Other than
in Xenopus laevis, hsp27 and hsp30 genes have been only found in the same organism in
topminnow and chicken (Norris et al., 1997; Katoh et al., 2004).
1.6.2.1  Structure of HSP30 in Xenopus laevis
In Xenopus laevis, the HSP30 family is composed of multiple members.  Five acidic
hsp30 genes have been cloned and sequenced; hsp30 A-E. The hsp30A gene contains an
insertional mutation in the coding region and therefore only encodes a 10kDa protein. The
hsp30B gene was found to contain a frameshift mutation resulting in a TGA stop codon close to
the C terminus and is therefore considered a pseudogene.  The hsp30B gene does not contain an
HSE sequence and is not heat inducible in micro-injected oocytes.  Krone et al., (1992) were
responsible for the complete isolation of the hsp30C and D genes as well as the promoter and N-
terminal coding region of hsp30E. Hsp30 C and D both encode 24 kDa proteins.  Hsp30 genes A
and B are found in one cluster of genes and Hsp30 C-D are found in another cluster.  The genes
in their respective clusters are arranged in a head-to-tail formation.  These two clusters are
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closely related as there is a 99% sequence similarity between both the coding and flanking
regions of hsp30A and C as well as hsp30 B and E (Krone et al., 1992).  It is not known whether
the clusters arose either from a single duplication or several independent events.  The clone that
Bienz (1984) reported to contain hsp30 A and B did not include any upstream sequences and
therefore it is unknown whether a gene is present that is similar to the hsp30D gene.   The coding
region of hsp30D has a higher degree of similarity to the coding regions of hsp30A and C than to
hsp30B and E (Krone et al., 1992).  All five hsp30 genes were found to contain no introns
(Bienz, 1984; Krone et al., 1992).  In addition to hsp30A-E, two hsp30 cDNAs have been
identified; X4 and X5 (Bienz, 1984).
1.6.2.2  Stress induced HSP30 synthesis
Heat shock induction of HSP30 accumulation is followed by the assembly of HSP30 high
molecular weight complexes, which bind to denatured proteins.  These aggregates include
different isoforms of HSP30 as well as other proteins such as HSP70 (Ohan et al., 1998).  HSP30
is phosphorylated by mitogen-activated kinase-activated protein kinase-2 (MAPKAPK-2) during
recovery from stress (Fernando et al., 2003) and forms smaller multimeric HSP30 complexes,
which have a reduced binding activity to denatured proteins (Heikkila, 2003). The proteins that
are released from the HSP30 aggregates are refolded and reactivated by an ATP-dependent
molecular chaperone folding system that may include proteins such as HSP/HSC70 (Heikkila et
al., 2004).  Also, phosphorylation was found to destabilize the HSP30 multimeric complex and
inhibit its chaperone activity (Fernando et al., 2003).
All members of the acidic HSP30 family members in Xenopus laevis are stress inducible.
Heat shock and other stressors including sodium arsenite, hydrogen peroxide and herbimycin A
have been shown to induce hsp30 gene expression in A6 cells (Darasch et al., 1988; Heikkila et
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al, 1987; Briant et al, 1997; Muller et al., 2004).  A synergistic effect of hsp30 gene expression
was observed when a combination of stressors was used (Heikkila et al., 1987; Briant et al,
1997).
1.6.2.3  Function of HSP30
During heat shock, HSP30C is able bind citrate synthase (CS) and luciferase (LUC),
inhibit their aggregation and maintain them in a soluble state (Fernando & Heikkila, 2000).
Experiments using HSP30 terminal deletion mutants determined that the C-terminal was
necessary for molecular chaperone activity, while the N-terminal was not.  It is thought that the
multiple polar amino acids found at the C-terminal end of HSP30C may be involved in
preserving the solubility of HSP30C itself as well as that of the target protein.  It is also possible
that the C-terminal is required for the binding of HSP30C to the target protein (Fernando &
Heikkila, 2000; Abdulle et al., 2002).  HSP30D also acts as a molecular chaperone, however it
differs from HSP30C in 19 amino acids and is less effective as a molecular chaperone than
HSP30C (Abdulle et al., 2002).
1.7  Inhibition of the Heat shock Response
Hyperthermic treatment of cancer cells leads to damage of proteins and membrane
structures (Dewey, 1989; Yatvin and Cramp, 1993;  Lepock, 2004) and eventual cell death either
through apoptosis or necrosis (Brown and Attardi, 2005).  Thermal therapy is currently used in
cancer treatment, however, it does have some important drawbacks that limit its effectiveness.  A
stress response is initiated in response to hyperthermia, which leads to the induction of HSPs
(Coss, 2005).  As mentioned earlier, various HSPs act as molecular chaperones, which protect
cellular proteins and direct denatured proteins for proteolysis.  HSPs also act as inhibitors of
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apoptosis, which block apoptotic signalling, inhibit apoptosis and improve the survival of the
cells (Jäättelä, 1999; Jolly and Morimoto, 2000; Parcellier et al, 2003; Beere, 2004).  Therefore a
method to inhibit heat shock protein induction prior to thermal therapy of cancer cells would
augment the success of this treatment.
1.7.1  Quercetin
The flavonoid quercetin (3,3’,4’,5,7-pentahydroflavon) is a specific hsp synthesis inhibitor
in several cell lines including colon carcinoma (COLO 320M, HT-29 (Hosokawa et al., 1990;
Lee et al., 1994), HeLa (Hosokawa et al., 1990; Hansen et al., 1997), erythroleukemia (K562)
(Elia & Santoro, 1994) and breast carcinoma cells (MDA-MB-231) (Hansen et al., 1997).
Quercetin also inhibits the activity of several protein kinases (Gschwendt et al., 1983; Levy et
al., 1984; Matter et al., 1992) as well as the growth of cells in vitro (Larocca et al., 1990;
Scambia et al, 1991; Ranelletti et al., 1992; Avila et al., 1994).
Experiments by Hansen and colleagues, (1997), comparing the inhibition of hsp synthesis in
HeLa and MDA-MB-231 cells, demonstrated that quercetin acts in a cell type specific manner.
A gel shift assay established that HeLa cells treated with quercetin had decreased binding of HSF
to HSE.  This is consistent with other experiments performed on HeLa and COLO 320M cell
lines (Nagai et al., 1995; Hosokawa et al., 1992).  Interestingly, the same experiment performed
with MDA-MB-231 cells determined that there was a decrease in hsp synthesis but no decrease
in binding of HSF to HSE.  This is similar to results found with the HT-29 and K562 cell lines
(Lee et al., 1994, Elia et al., 1996).  There was only small decrease in HSF1 levels when MDA-
MB-231 cells were treated with quercetin.  Hansen and colleagues, (1997) therefore concluded
that the decrease of hsp expression seen in quercetin treated MDA-MB-231 cells following heat
shock was due to a lack of activation of HSF and/or a lack of initiation of hsp gene transcription.
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1.7.2  KNK437
Recently, a benzylidene lactam compound, KNK437, was created by the Kaneka
Corporation (Takasago, Japan) and found to be a potent hsp gene expression inhibitor (Figure 2).
Much less is known about KNK437 than quercetin.  However, it is less toxic to cells as well as
more effective in inhibiting thermotolerance (Yokota et al., 2000).  It has been suggested that
KNK437 may inhibit HSF1 activation or inhibit the interaction between HSF1 and HSE
(Hosokawa et al., 1992).  In support of the latter possibility, it was determined by a gel shift
assay using heat shocked human squamous carcinoma cells that KNK437 reduced heat-induced
binding of HSF1 to HSE.  The reduced binding of HSF1 to HSE did not result from a decrease of
HSF1 as the level of HSF1 was not affected by KNK437 (Ohnishi et al., 2004).  In support of
these results, it was reported that exposure of the human esophageal cancer cell line, TE-2, did
not result in a decrease in the amount of HSF1 granules nor did it result in a change in
appearance of the granules (Nonaka et al., 2003).  HSF1 granules were observed when cells were
exposed to heavy metals or proteasome inhibition.  A possible explanation for decreased binding
of HSE to HSF1 was that KNK437 may inhibit the trimerization of HSF1 which is required for
binding to HSE.  Another possibility was that KNK437 may have inhibited the phosphorylation
of HSF1 after heating, thereby inhibiting its activation.  Unphosphorylated HSF1 is able to bind
to HSE but is unable to acquire transcriptional activity (Cotto et al., 1996). Previous literature
has indicated that KNK437 also inhibited the induction of HSPs in vivo (Koishi et al., 2001).
While it was reported that KNK437 did not have any anti-tumorigenic activity on its own,
KNK437 did not interfere with the activities of protein kinase A or C or tyrosine kinase (Yokota
et al., 2000).
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Figure 3.  Structure of the heat shock inhibitor KNK437.
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1.7.3  Heat shock protein gene expression inhibition in Xenopus A6 cells
Manwell and Heikkila (2007) found that both quercetin and KNK437 inhibited the
expression of hsp30, hsp47 and hsp70 genes in heat shocked A6 cells. However KNK437 was
found to be more effective in inhibiting hsp gene expression than quercetin.  Finally, KNK437
was capable of inhibiting the acquisition of thermotolerance in A6 cells (Manwell & Heikkila,
2007).  A similar finding was made with COLO 320DM and human esophageal cancer cell lines
(Yokota et al., 2000; Nonaka et al., 2003).
1.8  Objectives
There are many known inducers of the heat shock response, however there are few known
specific inhibitors.  In our laboratory and in others, KNK437 has proven to be a very effective
inhibitor of heat shock factor (Yokota et al., 2000; Manwell and Heikkila, 2007).  KNK437 was
effective at inhibiting heat shock-induced hsp30 gene expression in Xenopus laevis A6 cells
(Manwell and Heikkila, 2007).  However, it was not known whether KNK437 could inhibit
Xenopus hsp30 gene expression induced by non-heat shock stressors.  The main objectives of
this study are listed below:
• To characterize the accumulation of hsp30 mRNA as well as HSP30 and HSP70 protein in
Xenopus A6 cells treated with sodium arsenite, cadmium chloride or herbimycin A using
northern and western blot analyses.
•   To determine the ability of the heat shock factor inhibitor, KNK437, to inhibit the
accumulation of hsp30 mRNA, HSP30 and HSP70 in Xenopus A6 cells treated with sodium
arsenite, cadmium chloride, or herbimycin A treatments by means of northern and western
blot analyses.
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• To observe the intracellular localization of sodium arsenite-, cadmium chloride- and
herbimycin A-induced accumulation of HSP30 in Xenopus A6 cells incubated either in the
absence or presence of KNK437 using immunofluorescence and confocal laser scanning
microscopy.
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2  Experimental Procedures
2.1  Xenopus laevis A6 Cell Culture and Treatment
Xenopus laevis kidney A6 epithelial cells were acquired from ATCC (American Type
Culture Collection, Rockville, Maryland).  The cells were cultured in Leibovitz (L)-15 media
(Sigma, Oakville, Ontario) supplemented with 10% fetal bovine serum and 1%





 flasks.  Upon confluency, cells were washed with 2 mL versene [0.02% (w/v) KCl,
0.8% (w/v) NaCl, 0.02% (w/v) KH2PO4, 0.115% (w/v) Na2HPO4, 0.02% (w/v) sodium
ethylenediaminetetraacetic acid (Na2EDTA)] and then with 1 mL of 1X trypsin (Sigma) diluted
in 100% Hank’s balanced salt solution (HBSS, Sigma) until cells began  to detach from the flask.
Ten mL of fresh media was then added to the detached cells, which were divided into additional
flasks. Cell treatments were performed 2 or 3 days after cell splitting to allow the cells to reach
90-100% confluence. Cell treatments with HSF inhibitor KNK437 (N-formyl-3,4-
methylenedioxy-benzylidene- -butyrolactam; Calbiochem, Gibbstown, New Jersey) were
performed either 2 or 6 h prior to chemical or heat treatments with 100 uM KNK437 dissolved in
dimethylsulphoxide (DMSO; Sigma).  The heat shock treatments were at 33 or 35ºC followed by
a 2 h recovery period at 22°C for protein isolation and without recovery for the isolation of
RNA.  The chemical treatments included various concentrations of cadmium chloride or sodium
arsenite dissolved in distilled water or herbimycin A dissolved in DMSO. Cells were harvested
immediately following treatment by washing the cells in 2 mL of 65% HBSS, and then removed
in 1mL of 100% HBSS by scraping.  The cells were pelleted at 14,000 rpm for 1 min and pellets
were stored at -80°C until protein or RNA isolation.
26
2.2  Hsp30C antisense riboprobe production and Northern blotting
2.2.1  Hsp30 template construction
The entire open reading frame of the hsp30C gene was previously inserted into the
pRSET expression vector (Invitrogen, Carlsbad, California) by Pasan Fernando (Fernando &
Heikkila, 2000).  Plasmids containing the hsp30C insert were transformed into Escherichia coli
DH5α cells.  Individual colonies were inoculated into 15 mL Falcon tubes and grown overnight
in 5 mL of LB broth [1% (w/v) tryptone-peptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH
7.5] containing 100 µg/mL ampicillin at 37ºC.
2.2.2  Plasmid isolation
Cells were pelleted in a centrifuge (Eppendorf Centrifuge 5810R, Brinkmann Instruments
Ltd., Mississauga, Ontario) at 5,000 rpm for 10 min at 4ºC.  Plasmid DNA was isolated by
resuspending the pelleted bacterial cells in 200 µL of an ice-cold solution made of 50 mM
glucose, 25 mM Tris (pH 8.0) and 1 mM EDTA (pH 8.0) and transferring the mixture into a
microcentrifuge tube where they were lysed by mixing gently with 200 µL of a solution made
with 0.2 M NaOH and 1% (w/v) SDS (sodium dodecyl sulfate).  The tubes were kept on ice for
the remainder of the plasmid isolation experiment.  An ice-cold solution of 3 M potassium
acetate and 5 M glacial acetic acid was added and the tubes were again mixed gently and placed
on ice for 5 min.  Following centrifugation at 14,000 rpm for 5 min at 4
o
C, the supernatant was
transferred to a new tube.  A 2 h RNase A treatment (10 µg/mL; BioShop, Burlington, Ontario)
was performed at 37
 o
C to eliminate RNA from the sample.  Next, 600 µL of phenol:chloroform
(1:1) was added and the sample was vortexed to mix.  The tube was centrifuged at 14,000 rpm
for 3 min at 4°C and the upper aqueous layer was transferred to a new tube.  The
phenol/chloroform step was repeated.  A 600 µL solution of isoamyl alcohol:chloroform (1:24)
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was added, the tube was vortexed and centrifuged at the settings mentioned above.  Again the
upper aqueous layer was transferred to a new tube.  To precipitate the nucleic acids, 600 µL of
isopropanol was added. The samples were vortexed and incubated at room temperature for 2
min.  They were then centrifuged at 14,000 rpm for 5 min at room temperature. The supernatant
was removed and 500 µL of 70% ethanol was added to wash the pellet.  The sample was
centrifuged at 14,000 rpm for 2 min at 4°C.  The ethanol was removed and the ethanol wash step
was repeated.  The pellets were allowed to air dry and were then resuspended in 50 µL distilled
water and stored at -20°C.
2.2.3  In vitro transcription
The plasmid containing the hsp30C insert as mentioned above was linearized using the
PvuII restriction enzyme (Roche Molecular Biochemicals, Laval, Quebec).  The cut plasmid was
then run on a 1% (w/v) agarose gel in 1x TAE.  The hsp30C insert was cut out using a razor
blade and extracted from the gel using a DNA extraction tube (Millipore Corp., Bedford,
Massachusetts) which was centrifuged at 5,000 rpm for 10 min. The DNA therefore passed
through the filter in TAE buffer.  The filter was removed and the DNA was precipitated by
adding 100% ice-cold ethanol (2x volume) and 3 M sodium acetate (pH 5.2, 1/10 of volume).
The tube was placed at -80
o
C for 30 min and then centrifuged at 14,000 rpm for 10 min at 4
o
C.
The supernatant was discarded and the pellet was washed in 1 mL of 70% ice-cold ethanol and
centrifuged at the settings mentioned above.  The ethanol was removed and the ethanol wash step
was repeated.  The pellet was air dried and resuspended in 20 µL of sterile water and kept at -
20°C.
In vitro transcription was used to generate digoxygenin (DIG)-labelled riboprobes.  Each
in vitro transcription reaction contained 4 µL of linearized DNA template, 4 µL of rNTP mix
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[2.5 mM rGTP, 2.5 mM rATP, 2.5mM rCTP, 1.625 mM rUTP (Promega, Nepean, Ontario),
0.875 mM DIG-11-UTP (Roche Molecular Biochemicals), 1.5 µL diethylpyrocarbonate
(DEPC)-treated water, 4 µL of 100 mM dithiothreitol to a final concentration of 20 mM
(Promega), 4 µL of 5X transcription buffer to a final concentration of 1x (MBI Fermentas,
Burlington, Ontario), 0.5 µl RNase inhibitor (MBI Fermentas) and 40 IU of SP6 RNA
polymerase (Roche Molecular Biochemicals).  The in vitro transcription reaction was performed
for 1 h at 37°C.  To remove any remaining DNA template, 2 µL of RNase-free DNase 1 (Roche
Molecular Biochemicals) was added for 10 min at 37ºC.  In vitro transcripts were then
precipitated with the addition of 10 µL of 3 M sodium acetate (pH 5.2), 80 µL of TES [10 mM
Tris-HCl (pH 7.4), 5 mM EDTA (pH 8.0), 1% (w/v) SDS] and 220 µL of ice-cold 100% filtered
ethanol.  The reaction was incubated at −80ºC for 30 min and then centrifuged at 14,000 rpm for
15 min at 4ºC.  The supernatant was removed and the pellet was air dried and resuspended in 21
µL of DEPC-treated water.  One µL was electrophoresed to verify the presence of the in vitro
transcript.  The remaining 20 µL was stored at −80ºC until northern blot analysis.
2.2.4  RNA isolation
RNA was isolated from A6 cell pellets using the Qiagen RNeasy Mini Kit (Qiagen,
Mississauga, Ontario) according to the manufacturers’ instructions in the RNeasy Mini
Handbook Animal Cell Protocol (2006).  RNA samples were quantified using a NanoDrop ND-
1000 UV-Vis Spectrophotometer, Waltham, Massachusetts).  Before the northern blot procedure,
the integrity of the isolated RNA was determined by running  2 µg of each sample on a 1.2%
formaldehyde agarose gel [1.2% (w/v) agarose, 10% (v/v) 10x MOPS (pH 7.0; 0.2 M 3-propane
sulphonic acid, 50 mM anhydrous sodium acetate, 10 mM EDTA, pH 8.0) and 16% (v/v)
formaldehyde].  The RNA samples were heat denatured for 10 min at 65ºC in a solution of 1 µL
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10X MOPS, 1.6  µL formaldehyde, 2 µL loading dye [0.2% (w/v) bromophenol blue, 1 mM
EDTA (pH 8.0) and 50% (v/v) glycerol], 5 µL formamide and 0.5 µg /mL ethidium bromide.
The samples were then placed on ice for 5 min and electrophoresed at approximately 100V for 1
h.
2.2.5  Northern Hybridization
Ten µg of isolated RNA prepared as described above with the exception of ethidium bromide
and was electrophoresed for 2 h at 100V on a 1.2% formaldehyde agarose gel also described
above.  The gel was then soaked in 0.05 M NaOH for 20 min and then rinsed in DEPC treated
water.  The gel was soaked twice in 20X SSC buffer [3 M sodium chloride, 300 mM sodium
citrate (pH 7.0)] for 20 min and then transferred onto a positively charged nylon membrane
(Roche Molecular Biochemicals) overnight by capillary action.  The blotting apparatus was set
up as follows.  The gel was place upside down onto a piece of blotting paper soaked in 20X SSC
(VWR, Mississauga, Ontario) which acted as a wick, that was set on a glass support over a
Pyrex® dish filled with 500 mL 20X SSC. The nylon membrane which was cut to the same size
as the gel, was placed on top of the gel and covered with 2 pre-soaked pieces of blotting paper. A
4 inch stack of paper towels was placed on top of the blotting paper and a 500 g weight was
placed on top of the paper towels.  The RNA was crosslinked to the membrane using a UV
Crosslinker (Ultra-lum Inc., Claremont, California) at 12,000 microJ/CM
2
.  The membrane was
soaked in 10% (v/v) glacial acetic acid for 5 min and then placed in 1X Blot Stain Blue
Reversible stain to determine if the transfer was successful and if the gel was loaded equally.
The membrane was then destained in DEPC water and photographed.  The membrane was
transferred placed in RNA pre-hybridization buffer [50% (v/v) formamide, 5X SSC, 0.02% SDS,
0.01% N-lauryl sarcosine, 2% blocking reagent] in a hybridization bag (SealPAK pouches,
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VWR) and placed in a Boekel Scientific Shake’N’Bake Hybridization Oven (VWR) at 65
o
C for
4 h.  Hybridization was then performed with a Digoxygenin-labelled hsp30C RNA antisense
riboprobe in RNA hybridization buffer overnight at 65
o
C.
To remove unbound probe from the membrane, SSC (saline sodium citrate) stringency
solutions in decreasing concentrations were used as described below.  First the membrane was
washed twice in a solution of 2X SSC (with 0.1% (w/v) SDS) for 5 min at room temperature.
Then a 15 min wash was performed in 0.5X SSC (with 0.1% (w/v) SDS) at 65°C followed by a
15 min wash in 0.1X SSC (with 0.1% (w/v) SDS) at 65°C.  The rest of the experiment was
performed at room temperature.  Next the membrane was placed in washing buffer [100 mM
maleic acid, 0.3% (v/v) Tween 20] for 1 min.  The membrane was blocked for 30 min at room
temperature in blocking solution [2% (w/v) blocking reagent, 10% (v/v) maleic acid buffer (pH
7.5)] and for another 30 min in blocking solution containing a 1:8,000 dilution of Anti-DIG-
alkaline phosphatase-conjugated Fab fragment antibody (Roche Molecular Biochemicals).  To
remove any unbound secondary antibody, the membrane was washed twice for 20 min each in
washing buffer and then placed for 2 min in detection buffer [0.1 M Tris-HCl (pH 9.5), 0.1 M
NaCl].  Finally the membrane was placed in a fresh hybridization bag and incubated for 10 min
in an even coat of the chemiluminescent reagent, CDP-Star (Roche Molecular Biochemicals).
The membrane was visualized using a DNP chemiluminescent imager (DNR Bio-Imaging
Systems Ltd., Kirkland, Quebec) according to the manufacturer’s instructions.
2.3  Western Blotting
2.3.1  Protein Isolation
Protein was isolated from A6 cell pellets using homogenization buffer at pH 7.4 [160
mM sucrose, 1.6 mM glycol tetraacetic acid (EGTA), 0.8 mM ethylenediaminetetraacetic acid
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(EDTA), 32 mM NaCl, 24 mM N-Z-hydroxylethylpiperazine-N'-2 ethane sulfonic acid
(HEPES), 1% (w/v) SDS, 100 µg/mL phenylmethyl-sufonyl fluoride (PMSF), 1 µg/mL
aprotinin, 0.5 µg/mL leupeptin, pH 7.4]. The samples were sonicated (output 4.5, 65% duty cycle
for 15 , 1 s bursts) using a Branson sonifier (Branson Sonic Power Co., Danbury, Connecticut)
and then centrifuged at 14,000 rpm for 30 min at 4°C to pellet cellular debris.  The protein
contained in the supernatant was stored at -20
 o
C.
2.3.2  Protein quantification
Protein was quantified using a bicinchoninic acid (BCA) Protein Assay Kit (Pierce,
Rockford, Illinois).  A bovine serum albumin (BSA; Bioshop) protein standard was created by
diluting BSA in distilled water at concentrations ranging from 0 to 2 mg/mL.  Protein samples
were diluted to a concentration of 1:2 in distilled water.  Ten µL of BSA standards and protein
samples were transferred in triplicate into a 96 well polystyrene plate.  Then 80 µL of BCA
reagent A and B at a ratio 50:1 were added to the BSA and protein samples (Pierce).  The plate
was tapped lightly on the side to mix and then incubated at 37°C for 30 min.  The plate was then
read at 562 nm using a Versamax Tunable microplate reader (Molecular Devices, Sunnyvale,
California).  A standard curve was created using the concentrations of the BSA protein standards
which was used to determine the concentration of the protein samples.
2.3.3  Western Blotting
Twenty µg of  protein was separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) using a BioRad Mini Protean III system (BioRad, Mississauga,
Ontario).  Twenty µg of protein was diluted in distilled water to 20 µL.  Five µL of 5x loading
dye [0.0625 M Tris pH 6.8, 10% (v/v) glycerol, 2% (w/v) SDS, 5% (v/v) β-mercaptoethanol,
32
0.00125% (w/v) bromophenol blue] was added to a final concentration of 1x.  The protein was
denatured by boiling for 10 min and pulse spun before loading onto the gel.
The separating gel [12% acrylamide, 0.32% n’n’-bis methylene acrylamide, 0.375 M Tris
(pH 8.8), 1% SDS, 0.2% ammonium persulfate (APS) and 0.14% tetramethylethylenediamine
(TEMED)], was poured and covered in 100% ethanol to create an even surface.  The gels were
allowed to polymerize for 25 min.  The ethanol was removed and the stacking gel [4%
acrylamide, 0.11% n’n’-bis methylene acrylamide, 0.125 M Tris (pH 6.8), 1% SDS, 0.4% APS
and 0.21% TEMED] was poured and the comb was inserted.  Twenty-five min later, the comb
was removed and the protein was loaded in the wells.  The gel was run at 90V through the
stacking gel and at 170V through the separating gel.
Nitrocellulose  membranes were soaked in transfer buffer [25 mM Tris, 192 mM glycine,
20% (v/v) methanol] for 30 min.  After the gels were finished running, they were also soaked in
transfer buffer for 10-15 min.  The proteins on the gel were transferred onto the nitrocellulose
membrane using a BioRad Trans-Blot Semi-Dry Transfer Cell  (BioRad) at 20V for 20 min.
Ponceau S stain [0.19% (w/v) Ponceau-S, 5% (v/v) acetic acid] was used to stain the membrane
to determine whether the transfer was successful and the protein was loaded equally.  The
membrane was incubated for 1 h in Tris buffered saline solution (TBS) [2 mM Tris (pH 7.5),
0.1% Tween 20 (Sigma), 30 mM NaCl] with Tween 20 (TBS-T) containing 5% (w/v) Carnation
skim milk powder creating a 5% blocking solution. The membrane was then incubated in fresh
blocking solution with rabbit polyclonal anti-HSP30 antibody (1:3,000), HSP70 (1:200) or actin
(1:200) for 1 h.  The membrane was washed in TBS-T and then and incubated with alkaline
phosphatase (AP)-conjugated goat anti-rabbit secondary antibody at a 1:3,000 dilution (BioRad).
Again the membrane was washed and then was incubated in 51% alkaline phosphatase detection
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buffer [100 mM Tris base, 100 mM NaCl, 50 mM MgCl2] diluted in distilled water, 0.3% of 300
mg Nitro blue tetrazolium chloride (NBT), 0.17% of 150 mg 5-Bromo-4-chloro-3-indolyl
phosphate, toluidine salt (BCIP).
2.4  Immunocytochemistry and Laser Scanning Confocal Microscopy
The protocol followed for immunocytochemistry was as described by Spector et al.
(1998).  Xenopus laevis A6 cells were grown on 22 x 22 mm, flame sterilized glass coverslips
which were previously treated in a basic solution [48% distilled water, 50% mL 100% filtered
ethanol and 2% 10M NaOH] to ensure that cells adhered to the coverslip.  Once the cells were
confluent on the coverslips (approximately 48 h after cell seeding), heat shock or chemical
treatments were performed as described in section 2.1. Cells were first washed twice with
phosphate buffered saline (PBS; 8% NaCl, 0.2% KCl, 0.2% KH2PO4, 2.1% Na2HPO4·10H2O, 1
mM MgCl2, 1 mM CaCl2) and fixed in 3.7% (w/v) paraformaldehyde in PBS.  The cells were
washed in PBS and then permeabilized in 0.3% (v/v) Triton X-100 (Sigma) in PBS.  The cells
were washed again in PBS and then incubated for 1 h in 3.7% (w/v) BSA fraction V (Sigma) in
PBS, filter sterilized using a 0.4 µm filter (Pall Filtration Corporation, Mississauga, Ontario).
Indirect labeling was performed using a 1:500 dilution of rabbit anti-Xenopus HSP30 polyclonal
antibody in 3.7% BSA fraction V for 1 h.  PBS washes removed any unbound antibody.  The
coverslips were then incubated in a secondary mouse anti-rabbit IgG antibody conjugated with
Alexa-488 (Invitrogen) at a 1:2000 dilution in 3.7% (w/v) BSA fraction V for 30 min.  Again the
coverslips were washed to remove unbound secondary antibody.  The cells were then incubated
in a 1:60 dilution of rhodamine-tetramethylrhodamine-5-isothiocyanate (TRITC; 300 U of
rhodamine phalloidin in 1.5 mL 100% methanol, Invitrogen) in 3.7% (w/v) BSA to directly label
F- actin.  The coverslips were washed in PBS and then mounted on a microscope slide with
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Vectashield (Vector laboratories Inc., Burlingame, California) containing 4,6-diamidino-2-
phenylindole (DAPI), which stains nucleic acids.  The coverslips were sealed onto the slides with
clear nail polish and the slides were kept at 4ºC.
The slides were imaged with an inverted laser scanning Zeiss Axiovert 200 confocal
microscope using LSM 510 META software (Carl Zeiss Canada Ltd., Mississauga, Ontario)
according to the manufacturers’ instructions.  Both 40x and 63x oil objectives were used for
imaging.
2.5  Xenopus HSP30C antibody purification
2.5.1  Expression of HSP30C recombinant protein
As mentioned earlier, the open reading frame of the hsp30C gene was previously inserted
into the pRSET expression vector (Invitrogen) by Pasan Fernando and transformed into
Escherichia coli DH5α cells.  Although DH5α cells are good hosts for storing plasmids, they are
not optimal for producing recombinant protein (Kroll et al, 1993).  The pRSETB plasmid was
therefore isolated from the DH5α cells and transformed into E. coli BL21 (DE3) cells.  BL21
cells are much more efficient in producing recombinant protein.
Transformed DH5α cells were grown from a glycerol stock as mentioned in section 2.2.1
and pRSETB plasmids were isolated as in section 2.2.2.  The pRSET plasmids were then
digested as mentioned in section 2.23 and then both cut and uncut plasmids were electrophoresed
in a 1% agarose gel to determine that the plasmid insert was the correct size (Figure 4).
BL21 cells, from a glycerol stock previously used in our laboratory, were grown
overnight on LB plates [1% bacto-tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar, pH 7.0].  A
single colony was used to inoculate 5 mL of ZB media [1% N-Z-Amine A, 0.5% NaCl] and was
left to grow overnight at 37ºC.  CaCl2 was used to transform BL21 cells with the pRSETB
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plasmid containing the HSP30C insert.  Transformed cells were grown overnight on ZB plates
containing 100 µg/mL ampicillin.  As the pRSETB plasmid contains an ampicillin resistance
gene, this ensures that only cells containing the plasmid would grow.  A single colony of
transformed BL21 cells were grown overnight in a 10 mL culture of ZB + amp (100 µg/mL).
Ten mL of overnight culture was added to 500mL of M9ZB +  amp [1% N-Z-Amine A, 0.5%
NaCl, 0.1% NH4Cl, 0.3% KH2PO4, 0.6% Na2HPO4, 0.4% glucose, 1mM MgSO4, 50 µg/mL
ampicillin].  Isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of
1.0 mM to induce the production of recombinant protein.  After cells grew for 4-5 h,  they were
homogenized in guanidium lysis buffer (6.0 M guanidine hydrochloride, 20 mM Na2HPO4, 500
mM NaCl, pH 7.8) and sonicated using a using a Branson sonifier (Branson Sonic Power Co.)
for 3 repetitions of 20, 1 s bursts (70% duty cycle and 5 output), then centrifuged at 5000 rpm in
a Sorval RC 5B Plus centrifuge using the SS-34 rotor for 30 min at 4
o
C to pellet the cellular
debris.  The lysate (supernatant) was removed and stored at -20ºC until purification.
2.5.2  Purification of HSP30C recombinant protein
HSP30C recombinant protein was purified using a Poly Prep chromatography column
(BioRad) using ProBond resin (Invitrogen) containing nickel under denaturing conditions.  Three
mL of resin was added to the column and centrifuged at 100 rpm for 2 min.  The overlaying
storage buffer was removed and  the column was washed twice with 5 mL of distilled water and
then twice with 8 mL of denaturing buffer [8.0 M urea, 20 mM NaPO4, 0.5 M NaCl, pH 7.8].
Five mL of bacterial lysate, pH adjusted to 7.8, was added to the column and bound for 45 min at
room temperature on an orbital nutator (Boekel Scientific, Feasterville, Pennsylvania) and then
centrifuged at 2,000 rpm to separate unbound lysate, which was removed.  This process was
repeated several times with additional bacterial lysate.  The washing process consisted of
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agitation on the orbital nutator for 2 min, centrifugation at 2,000 rpm for 3 min and the removal
of the supernatant.  The column was washed 3 times with 5 mL denaturing buffer at pH 6, 5
times at pH 5.3 and 3 times at pH 5.  The protein was then eluted off the column in 5 mL
denaturing buffer at pH 4 in 1 mL fractions.  The resin was packed by centrifugation at 2,000
rpm for 30 s and an additional 5 mL denaturing buffer at pH 4 was added to the column.  The
protein was again eluted in 1 mL aliquots.  Twenty mL was removed from each of the aliquots
and analyzed by SDS page as described in section 2.33 to determine which aliquots contained the
recombinant protein.  The aliquots containing recombinant protein were then dialyzed to remove
the urea.  The dialysis tubing was prepared by soaking in 500 mL distilled water for 15 min and
then in 10 mM sodium bicarbonate at 80ºC for 30 min.  The tubing was transferred to 500 mL of
100 mM EDTA for 30 min and then to 500 mL of distilled water at 80ºC for 30 min.  Finally the
tubing was washed inside and out with distilled water and soaked in TEN buffer [50 mM Tris, 25
mM NaCl, 0.2 mM EDTA, pH 8.0] for 15 min.  The eluted protein was poured inside the tubing
and clamped at both ends.  The tubing was placed in a beaker containing 100 to 1,000 times the
amount of eluted protein and stirred gently at 4
o
C for 3 h.  The tubing was then transferred to a
beaker containing fresh TEN buffer and stirred gently overnight at 4
o
C.  The protein was
concentrated using a MicroSep 3K Concentrator Column (Pall Filtration Corp.) by centrifugation
at 5000 rpm at 4
o
C until the sample was concentrated to the desired volume.  The protein was
quantified with a BCA assay as described in section 2.3.2 and was stored at –20
 o
C.  Twenty µL
of purified recombinant protein was electrophoresed by SDS page as described in section 2.3.3
along with 20 µL samples of uninduced bacterial lysate and unpurified recombinant protein and
was visualized using Coomassie Brilliant Blue R-250 staining (Figure 5).
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2.5.3  Polyclonal antibody production
The rabbit anti-HSP30 serum had been previously prepared.  HSP30 recombinant protein
was diluted to 1.0 µg/µL in sterile 0.85% saline solution followed by the addition of an equal
volume of Freund’s Complete Adjuvant (Sigma) and injected into the rabbit using an an 18-
gauge needle. Three additional protein injections were given at 3-week intervals with the
Freund’s Incomplete Adjuvant (Sigma) being substituted for Freund’s Complete Adjuvant. At
the end of the twelve week period, the rabbit was euthanised.  The serum was separated from the
rest of the blood and was stored at -20˚C.
In order to separate the HSP30 antibody from the crude rabbit serum, ProBond resin was
added to a PolyPrep Chromatography Column and centrifuged.  Unless otherwise mentioned, all
wash steps were performed on an orbital nutator and followed by centrifugation at 1,000 rpm for
2 min and removal of the supernatant.  Five mL of distilled water was used to wash the column 3
times.  The column was then washed in 8 mL of equilibration buffer [50 mM Tris, 2 mM NaCl,
pH 7.4] 3 times.  Five mL of recombinant protein was diluted to a final volume of 8 mL in
equilibration buffer.  The column was agitated to 1 h on an orbital nutator at 4ºC.  Eight mL of
TBST [25 mM Tris, 150 mM NaCl, 2.5 mM KCl, 0.1% Tween-20] was added to wash the
column. The rabbit anti-HSP30 serum was diluted 1:4 in TBST and bound to the column
overnight at 4ºC and then washed in 5 mL of TBST 3 times.  The column was washed 5 times
with 5 mL of equilibration buffer, and then 5 times in 5 mL of wash buffer [50 mM Tris, 150
mM NaCl, pH 7.4].  The antibody was eluted from the column with the addition of 2 mL of 4 M
MgCl2 for 15 min at 4
o
C.  The supernatant was allowed to drain out the column and collected.
Another 2 mL of MgCl2 was added and again the flow through was collected.  The flow through
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was combined and the antibody was dialyzed and concentrated as described in section 2.5.2.  The
antibody was then stored at -20ºC.
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Figure 4.  Confirmation of the HSP30C insert in pRSETB plasmids.
Plasmids containing Xenopus hsp30C cDNA were isolated from DH5α cells, as described in
Experimental Procedures. Both uncut pRSETB with the HSP30C insert and pRSETB plasmids
digested with PvuII containing the HSP30C insert were electrophoresed on a 1% agarose gel to
confirm the presence and size of the HSP30C insert.  The ladder shown is a 1 Kb ladder and the














































































































































Figure 5.  Purification of the Xenopus laevis HSP30C recombinant protein.  Xenopus laevis
HSP30C was overexpressed in BL21 cells by induction with IPTG. The BL21 cell lysates
containing the recombinant protein bound a nickel affinity column through their histidine tag.
The recombinant protein was then purified as described in Section 2.5.2 and analysed by SDS-
PAGE and visualized by Coomassie Brilliant Blue R-250 staining. Lane 1 contains molecular
weight markers shown in kDa. Uninduced bacterial lysate is seen in lane 2.  Induced and
unpurified bacterial lysate is seen in lane 3.  Lane 4 contains purified recombinant HSP30C











3.1  Examination of the effect of KNK437 on the stress-induced accumulation of hsp30
mRNA in Xenopus A6 cells
Initial studies, using Northern hybridization analysis, examined the effect of heat shock,
sodium arsenite, cadmium chloride and herbimycin A on hsp30 mRNA accumulation in Xenopus
laevis A6 kidney epithelial cells. As shown in Figure 6, hsp30 mRNA was not detectable in
control A6 cells. However incubation of cells at either 33 or 35 ºC for 2 h induced the
accumulation of this message. Treatment of A6 cells with 10 µM sodium arsenite for 4 h resulted
in a small accumulation of hsp30 mRNA whereas cells treated with 20 or 30 µM resulted in
larger increases in the relative level of this mRNA. While incubation of cells in the presence of
100 µM cadmium chloride induced a small accumulation of message, treatment of A6 cells with
200 or 300 µM resulted in enhanced hsp30 mRNA levels.  Finally, a small amount of hsp30
mRNA was noted in A6 cells treated with 0.25 µg/ml of herbimycin A. The relative level of this
message increased with increased herbimycin A concentrations up to 2 µg/ml.
The next phase of this study evaluated the effect of the heat shock factor inhibitor,
KNK437, a benzylidene lactam compound, on stress-induced hsp30 mRNA accumulation.  A 2 h
pre-treatment with 100 µM KNK437 at 22°C reduced the accumulation of hsp30 mRNA
following treatment with the stressors mentioned above, however the relative amount of
inhibition of hsp30 mRNA accumulation differed depending on the stressor involved.
Densitometric analysis using ImageJ software (Version 1.38) was performed on the blots to
determine the difference in densities between samples treated with the stressor only, versus
samples pre-treated with KNK437 before treatment with the stressor.   The difference was
expressed as % inhibition and was averaged with the % inhibition of a total of 3 trials.  Statistical
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analysis was then performed using an unpaired T-test to determine whether the difference was
significant.  A 2 h pre-treatment with 100 µM KNK437 before heat shock at 33 or 35ºC resulted
in the reduction of hsp30 mRNA levels by 82% and 58%, respectively (Figure 7, 8).  Reductions
at both 33 and 35ºC were significantly different from heat shocked samples without a pre-
treatment with KNK437.  A 2 h pre-treatment with 100 µM KNK437 resulted in the inhibition of
hsp30 mRNA accumulation following a 20 µM sodium arsenite treatment for 2-12 h (Figure 9).
Although KNK437 was less efficient in inhibiting relative levels of hsp30 mRNA as the length
of sodium arsenite treatment increased, the reductions were significant.  At 2 h there was a 97%
reduction in hsp30 mRNA accumulation, whereas at 12 h there was only a 51% reduction
(Figure 10).  KNK437 also inhibited hsp30 mRNA accumulation induced by exposure of A6
cells to 200 µM cadmium chloride for 4-12 h (Figure 11).  At 4 h there was a 59% reduction in
the relative level of hsp30 mRNA accumulation, while at 12 h there was only a 33% reduction
(Figure 12).  KNK437 was most successful at inhibiting hsp30 mRNA accumulation in A6 cells
treated with 1 µg/mL herbimycin A for 2 –8 h (Figure 13, 14).  For example, after 2 h of
herbimycin A treatment, the extent of inhibition was 100%, whereas after 8 h, the reduction in
hsp30 mRNA levels was 88%.
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Figure 6.  The effect of various stressors on hsp30 mRNA accumulation in Xenopus A6
cells. A6 cells were heat shocked (HS) at 33 or 35°C for 2 h or treated with various
concentrations of either sodium arsenite (NaAs), cadmium chloride (Cd) or herbimycin A (HA)
for 4 h.  After treatments, the cells were harvested and total RNA was isolated.  Ten µg of RNA
was then analyzed by northern hybridization using an hsp30 antisense riboprobe as described in
Experimental Procedures.  A representative reversible RNA blot stain is shown in the bottom
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Figure 7.  Effect of KNK437 on heat shock-induced accumulation of hsp30 mRNA in A6
cells.   A6 cells were heat shocked at 33 or 35°C for 2 h with (+) or without (-) a 2 h pre-
treatment with 100 µM KNK437.  After treatment, cells were harvested and total RNA was
isolated.  Ten µg of RNA was then analyzed by northern hybridization using an hsp30 antisense
riboprobe.  A representative reversible RNA blot stain is shown in the bottom panel, which was
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Figure 8. Inhibition of heat shock-induced accumulation of hsp30 mRNA by KNK437.
Image J software (1.38) was used for densitometric analysis of hsp30 mRNA accumulation after
heat shock at 33 or 35°C for 2 h with or without a 2 h pre-treatment with 100 µM KNK437.  The
ability of KNK437 to inhibit HSP30 protein accumulation at each timepoint is graphed as %
inhibition.  Error bars represent standard error.  At each timepoint, significant differences are














































Figure 9.  Effect of KNK437 on sodium arsenite-induced accumulation of hsp30 mRNA in
A6 cells.   A6 cells were treated with 20 µM sodium arsenite for 2-12 h, with (+) or without (-) a
2 h pre-treatment with 100 µM KNK437.   After treatment, cells were harvested and total RNA
was isolated.  Ten µg of RNA was then analyzed by northern hybridization using an hsp30
antisense riboprobe.  A representative reversible RNA blot stain is shown in the bottom panel
which was used to confirm equal loading and transfer.
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Figure 10. Inhibition of sodium arsenite-induced accumulation of hsp30 mRNA by
KNK437.  Image J software (1.38) was used for densitometric analysis of hsp30 mRNA
accumulation after treatment with 20 µM sodium arsenite for 2-12 h with or without a 2 h pre-
treatment with 100 µM KNK437.  The ability of KNK437 to inhibit HSP30 protein accumulation
at each timepoint is graphed as % inhibition.  Error bars represent standard error.  At each












































Figure 11.  Effect of KNK437 on cadmium chloride-induced accumulation of hsp30 mRNA
in A6 cells.   A6 cells were treated with 200 µM cadmium chloride for 4-12 h, with (+) or
without (-) a 2 h pre-treatment with 100 µM KNK437.   After treatment, cells were harvested and
total RNA was isolated.  Ten µg of RNA was then analyzed by northern hybridization using an
hsp30 antisense riboprobe.  A representative RNA reversible blot stain is shown in the bottom
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Figure 12. Inhibition of cadmium chloride-induced accumulation of hsp30 mRNA by
KNK437.  Image J software (1.38) was used for densitometric analysis of hsp30 mRNA
accumulation after treatment with 200 µM cadmium chloride for 4-12 h with or without a 2 h
pre-treatment with 100 µM KNK437.  The ability of KNK437 to inhibit HSP30 protein
accumulation at each timepoint is graphed as % inhibition.  Error bars represent standard error.











































Figure 13.  Effect of KNK437 on herbimycin A-induced accumulation of hsp30 mRNA in
A6 cells.   A6 cells were treated with 1 µg/mL herbimycin A for 2-8 h, with (+) or without (-) a 2
h pre-treatment with 100 µM KNK437.   After treatment, cells were harvested and total RNA
was isolated.  Ten µg of RNA was then analyzed by northern hybridization using an hsp30
antisense riboprobe.  A representative RNA reversible blot stain is shown in the bottom panel
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Figure 14. Inhibition of herbimycin A -induced accumulation of hsp30 mRNA by KNK437.
Image J software (1.38) was used for densitometric analysis of hsp30 mRNA accumulation after
treatment with 1 µg/ml herbimycin A for 2-8 h with or without a 2 h pre-treatment with 100 µM
KNK437.  The ability of KNK437 to inhibit HSP30 protein accumulation at each timepoint is
graphed as % inhibition.  Error bars represent standard error.  At each timepoint, significant









































3.2  Examination of the effect of KNK437 on the accumulation of HSP30 protein in
Xenopus A6 cells using western blot analysis
The next stage of this study investigated the effect of heat shock, sodium arsenite, cadmium
chloride and herbimycin A on the accumulation of HSP30 protein in Xenopus A6 cells using
western blot analysis.  Again, densitometric analysis using ImageJ software (Version 1.38) was
performed on the blots to determine the difference in densities between samples treated with the
stressor only, versus samples pre-treated with KNK437 before treatment with the stressor.   The
difference was expressed as % inhibition and was averaged with the % inhibition of a total of 3
trials.  Statistical analysis was then performed using an unpaired T-test to determine whether the
difference was significant.
HSP30 protein was not detected in control cells maintained at 22°C (Figure 15).
Accumulation of members of the HSP30 family was observed when A6 cells were heat shocked
at 33 or 35°C for 2 h.  Treatment with 10 µM sodium arsenite for 12 h resulted in detectable of
HSP30 protein.  Increased accumulation of the relative levels of HSP30 protein was noted in
cells treated with 20 – 40 µM sodium arsenite for 12 h.  Detectable levels of HSP30 were also
observed with A6 cells treated with 200-400 µM cadmium chloride.  Slightly higher levels of
HSP30 were observed with higher concentrations of cadmium chloride.  Finally, a small amount
of HSP30 protein accumulation was observed when A6 cells were treated 0.25 µg/ml of
herbimycin A.  The relative amount of HSP30 protein increased when A6 cells were treated with
increasing herbimycin A concentrations ranging from 0.5 – 2 µg/ml (Figure 15).
The ability of KNK437 to inhibit the accumulation of HSP30 was determined by pre-
treating A6 cells with 100 µM KNK437 before treatment with either heat shock, sodium arsenite,
cadmium chloride or herbimycin A.  It was determined that a 2 h KNK437 pre-treatment time
64
was required to inhibit 100% of heat shock-induced HSP30 protein (Figure 16).  Also, a 2 h pre-
treatment of A6 cells with 100 µM KNK437 was sufficient to completely inhibit the
accumulation HSP30 protein induced by heat shock at 33°C for 2 or 4 h treatments (Figure 17,
18).  When A6 cells were treated with 20 µM sodium arsenite, there was a complete inhibition of
HSP30 after 6 and 8 h.  However by 24 h, there was only a 59% inhibition (Figure 19, 20).
Interestingly, there was almost a 100% inhibition of HSP70 protein by KNK437 up to 24 h
(Figure 19).  KNK437 also inhibited the accumulation of HSP30 protein induced by exposure of
A6 cells to 200 µM cadmium chloride.  There was a 100% reduction at 6 h and by 24 h,
KNK437 was still able to inhibit HSP30 protein accumulation by 90% (Figure 21, 22).  HSP70
protein was inhibited by KNK437 up to 24 h (Figure 21).  Finally, KNK437 completely inhibited
both HSP30 and HSP70 protein accumulation in A6 cells treated with 1 µg/mL herbimycin A
(Figure 23, 24).
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Figure 15.  The effect of various stressors on HSP30 protein accumulation in Xenopus A6
cells.   A6 cells were heat shocked (HS) at 33 or 35°C for 2 h or treated with various
concentrations of sodium arsenite (NaAs), cadmium chloride (Cd) and herbimycin A (HA) for 12
h.   After the stress treatments, cells were harvested and protein was isolated.  Twenty µg of
protein was then analyzed by western blot analysis using an anti-HSP30 antibody.  A
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Figure 16.  Effect of the length of KNK437 pre-treatment on heat shock-induced
accumulation of HSP30 protein in A6 cells.   A6 cells were pre-treated for 0-6 h with 100 µM
KNK437 (K) and then heat shocked at 33 °C for 2 h followed by a 2 h recovery.   After
treatment, cells were harvested and protein was isolated.  Twenty µg of protein was then
analyzed by western blot analysis using an HSP30 antibody.  A representative Ponceau S stain is
shown in the bottom panel which was used to confirm equal loading and transfer.
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Figure 17.  Effect of KNK437 on heat shock-induced accumulation of HSP30 and HSP70
protein in A6 cells.   A6 cells were heat shocked at 33°C for 2 h followed by a 2 h recovery,
with (+) or without (-) a 2 h pre-treatment with 100 µM KNK437.  After treatment, cells were
harvested and protein was isolated.  Twenty or 40 µg of protein were then analyzed by western
blot analysis using an HSP30 or HSP70 antibody, respectively.  A representative Ponceau S stain
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Figure 18. Inhibition of heat shock-induced accumulation of HSP30 protein by KNK437.
Image J software (1.38) was used for densitometric analysis of HSP30 protein accumulation after
heat shock at 33°C for 2-4 h, with or without a 2 h pre-treatment with 100 µM KNK437.  The
ability of KNK437 to inhibit HSP30 protein accumulation at each timepoint was graphed as %
inhibition.  Error bars represent standard error.  At each timepoint, significant differences are









































Figure 19.  Effect of KNK437 on sodium arsenite-induced accumulation of HSP30 and
HSP70 protein in A6 cells.   A6 cells were treated with 20 µM sodium arsenite with (+) or
without (-) a 2 h pre-treatment with 100 µM KNK437.  After treatment, cells were harvested and
protein was isolated. Twenty or 40 µg of protein was then analyzed by western blot analysis
using an HSP30 or HSP70 antibody, respectively.  A representative Ponceau S stain is shown in
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Figure 20. Inhibition of sodium arsenite-induced accumulation of HSP30 protein by
KNK437.  Image J software (1.38) was used for densitometric analysis of HSP30 protein
accumulation after treatment with 20 µM sodium arsenite for 6-24 h, with or without a 2 h pre-
treatment with 100 µM KNK437.  The ability of KNK437 to inhibit HSP30 protein accumulation
at each timepoint was graphed as % inhibition.  Error bars represent standard error.  At each

























































Figure 21.  Effect of KNK437 on cadmium chloride-induced accumulation of HSP30 and
HSP70 protein in A6 cells.   A6 cells were treated with 200 µM cadmium chloride with (+) or
without (-) a 2 h pre-treatment with 100 µM KNK437.  After treatment, cells were harvested and
protein was isolated.  Twenty or 40 µg of protein was then analyzed by western blot analysis
using an HSP30 or HSP70 antibody, respectively.  A representative Ponceau S stain is shown in
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Figure 22. Inhibition of cadmium chloride-induced accumulation of HSP30 protein by
KNK437.  Image J software (1.38) was used for densitometric analysis of HSP30 protein
accumulation after treatment with 200 µM cadmium chloride for 6-24 h, with or without a 2 h
pre-treatment with 100 µM KNK437.  The ability of KNK437 to inhibit HSP30 protein
accumulation at each timepoint was graphed as % inhibition.  Error bars represent standard error.










































Figure 23.  Effect of KNK437 on herbimycin A-induced accumulation of HSP30 and HSP70
protein in A6 cells.   A6 cells were treated with 1 µg/mL herbimycin A with (+) or without (-) a
2 h pre-treatment with 100 µM KNK437.  After treatment, cells were harvested and protein was
isolated.  Twenty or 40 µg of protein was then analyzed by western hybridization using an
HSP30 or HSP70 antibody respectively.  A representative Ponceau S stain is shown in the





KNK437 - +     - +     - +     - + - +     - +
Time (h)        0           6          8          12        16  24
83
Figure 24. Inhibition of herbimycin A-induced accumulation of HSP30 protein by
KNK437.  Image J software (1.38) was used for densitometric analysis of HSP30 protein
accumulation after treatment with 1 µg/ml herbimycin A for 6-24 h, with or without a 2 h pre-
treatment with 100 µM KNK437.  The ability of KNK437 to inhibit HSP30 protein accumulation
at each timepoint is graphed as % inhibition.  Error bars represent standard error.  At each









































3.3  Effect of KNK437 on the intracellular accumulation of HSP30 protein in Xenopus A6
cells
Immunocytochemistry and laser scanning confocal microscopy (LSCM) were used to
examine the effects of KNK437 on HSP30 accumulation and localization in A6 cells treated with
heat shock, sodium arsenite, cadmium chloride or herbimycin A.  Additionally, cell morphology,
and the structure of the actin cytoskeleton were observed following exposure to the above-
mentioned stressors.  Initial experiments were performed with a 2 h pre-treatment of 100 µM
KNK437 before treatment with heat shock or chemical stressors.  For western blot analysis, a 2 h
pre-treatment of 100 µM KNK437 was sufficient to reduce the accumulation of HSP30
significantly for all of the treatments mentioned above.  However, this was not the case for
immunocytochemical analysis which appeared to be more sensitive in detecting HSP30
accumulation (data not shown).  Since accumulation of HSP30 protein was considerably reduced
with a 6 h pre-treatment of 100 µM KNK437, this protocol was used in the following
experiments.
A6 cells grown at 22°C displayed actin stress fibers that transversed the cell in axial
bundles but did not accumulate detectable HSP30 protein (Figure 25 A, B).  Treatment with 100
µM KNK437 did not result in the accumulation of HSP30 or disturb the pattern of actin stress
fibers observed in control cells (Figure 25 C, D).  A6 cells heat shocked at 33°C for 2 h resulted
in the accumulation of HSP30 protein in nearly 100% of cells; located primarily in the cytoplasm
with very little accumulation in the nucleus (Figure 26 A, C).  With a 6 h pre-treatment of
KNK437, there was no detectable heat shock-induced HSP30 protein accumulation (Figure 26
E).  Also, there was no observable change in actin stress fibers in cells heat shocked at 33°C
(Figure 26 B, D).  However, when cells were pre-treated with KNK437 prior to heat shock at
33°C, there were occasional disruptions in the actin stress fibers (Figure 26 F).  Heat shock at
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35°C resulted in HSP30 accumulation in A6 cells in approximately 90% of the cells examined
(Figure 27 A, C).  While HSP30 protein was present in the cytoplasm, the majority of HSP30
staining was detected in the nucleus (Figure 27 A, C).  When HSP30 and DAPI staining were
overlapped, it was evident that HSP30 protein was not present in the nucleolus (B, D). When the
cells were pre-treated for 6 h with 100 µM KNK437, there was no detectable HSP30 protein in
the cells (E).  In a small percentage of cells heat shocked at 35°C both with or without pre-
treatment with KNK437, there was cell rounding possibly due to collapse of the actin
cytoskeleton (data not shown).
Treatment with 20 µM sodium arsenite resulted in an abundance of HSP30 protein in the
cytoplasm of all cells examined (Figure 28 A, C).  There was a collapse of the actin cytoskeleton,
with aggregation of actin at the periphery of the cell (Figure 28 D).  A 6 h pre-treatment with 100
µM KNK437 resulted in a reduction of HSP30 in 40-75% of the cells (Figure 28 E).  When the
concentration of sodium arsenite was reduced to 10 µM for 14 h at 22°C, there was an
accumulation of HSP30 in 90% of cells, located in the cytoplasm with an abundance near the
periphery of the cell (Figure 29 A, C).  Pre-treatment for 6 h with 100 µM KNK437 resulted in
inhibition of HSP30 protein in 97-100% of the cells (Figure 29 E).
A 14 h treatment with 100 µM cadmium chloride at 22°C resulted in the accumulation of
HSP30 in 80 - 100% cells.  HSP30 was located in the cytoplasm and absent from the nuclei
(Figure 30, A, C).  In a small number of cells HSP30 was found in a punctate pattern (Figure 30
A, C).   A 6 h pre-treatment with 100 µM KNK437 resulted in a decrease in HSP30 in 98 - 100%
of the cells (Figure 30 E).  Cadmium chloride on its own and when combined with KNK437
resulted in ruffling of the actin cytoskeleton at the periphery (Figure 30 D, F)
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Finally, a 14 h treatment with 1 µg/mL herbimycin A at 22°C resulted in the accumulation
of HSP30 in the cytoplasm of 60 - 80 % of cells (Figure 31 A, C).  Cells pre-treated for 6 h with
100 µM KNK437 before exposure to 1 µg/mL herbimycin A had no detectable levels of HSP30
protein (Figure 31 E).  Interestingly, a 2 h pre-treatment with KNK437 was also sufficient to
fully inhibit HSP30 protein accumulation (data not shown).  There was no observable change in
the actin stress fibers when cells were treated with herbimycin A, both with and without the
addition of KNK437 (Figure 31 B, D, F).
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Figure 25.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells maintained at 22°C.  A6 cells were grown on glass coverslips in L-15 media in the
absence (A-B) or presence (C-D) of 100 µM KNK437.   HSP30 was detected indirectly with an
anti-Xenopus HSP30 primary antibody and Alexa-488 secondary antibody conjugate (green).
Actin and nuclei were detected directly by staining with TRITC (red) and DAPI (blue),
respectively.  Cells were visualized using a Zeiss LSM 510 Meta laser confocal microscope. The
left column indicates HSP30 fluorescence, while the right column shows a merged image of and
HSP30, actin and DAPI fluorescence.  Cells treated with KNK437 maintain the same shape and





Figure 26.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells heat shocked at 33°C.  A6 cells were grown on glass coverslips in L-15 media and
were heat shocked at 33°C for 2 h followed by a 2 h recovery period at 22°C (A-F).  Other A6
cells were pre-treated with 100 µM KNK437 before being heat shocked at 33°C for 2 h followed
by a 2 h recovery period at 22°C (E-F).   HSP30 was detected indirectly with an anti-Xenopus
HSP30 primary antibody and Alexa-488 secondary antibody conjugate (green). Actin and nuclei
were detected directly by staining with TRITC (red) and DAPI (blue), respectively.  Cells were
visualized using a Zeiss LSM 510 Meta laser confocal microscope. The left column indicates
HSP30 fluorescence, while the right column shows a merged image of and HSP30, actin and
DAPI fluorescence. A low magnification was used to demonstrate the relative proportion of cells
expressing HSP30 (A-B).  The same cells were then imaged using a higher magnification (C-D).
Heat shock treatment of A6 cells at 33°C resulted in the accumulation of HSP30 in the
cytoplasm (arrow), however it is absent from the nucleus in some cells (asterisk) and present in








Figure 27.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells heat shocked at 35°C.  A6 cells were grown on glass coverslips in L-15 media and
were heat shocked at 35°C for 2 h followed by a 2 h recovery period at 22°C (A-F).  Other A6
cells were pre-treated with 100 µM KNK437 before being heat shocked.   HSP30 was detected
indirectly with an anti-Xenopus HSP30 primary antibody and Alexa-488 secondary antibody
conjugate (green). Actin and nuclei were detected directly by staining with TRITC (red) and
DAPI (blue), respectively.  Cells were visualized using a Zeiss LSM 510 Meta laser confocal
microscope.  The left column indicates HSP30 fluorescence, while the right column shows a
merged image of and HSP30, actin and DAPI fluorescence.  A low magnification was used to
demonstrate the relative proportion of cells expressing HSP30 (A-B).  The same cells were then
imaged using a higher magnification (C-D).  Heat shock treatment of A6 cells at 35°C resulted in
the accumulation of HSP30 in the cytoplasm (arrow) and in the nucleus (asterisk) of over 50% of







Figure 28.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells treated with 20 µM sodium arsenite for 14 h.  A6 cells were grown on glass
coverslips in L-15 media and were treated with 20 µM sodium arsenite for 14 h at 22°C (A-F).
Other cells were pre-treated with 100 µM KNK437 before being treated with sodium arsenite (E,
F).   HSP30 was detected indirectly with an anti-Xenopus HSP30 primary antibody and Alexa-
488 secondary antibody conjugate (green). Actin and nuclei were detected directly by staining
with TRITC (red) and DAPI (blue), respectively.  Cells were visualized using a Zeiss LSM 510
Meta laser confocal microscope.  The left column indicates HSP30 fluorescence, while the right
column shows a merged image of and HSP30, actin and DAPI fluorescence.  A low
magnification was used to demonstrate the relative proportion of cells expressing HSP30 (A-B).
The same cells were then imaged using a higher magnification (C-D). Treatment of A6 cells with
20 µM sodium arsenite for 14 h at 22°C resulted in the collapse of the actin cytoskeleton
(arrows).   HSP30 accumulation was present throughout the entire cytoplasm (circle arrow) and








Figure 29.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells treated with 10 µM sodium arsenite.  A6 cells were grown on glass coverslips in L-15
media and were treated with 10 µM sodium arsenite for 14 h at 22°C (A-F).  Other cells were
pre-treated with 100 µM KNK437 before being treated with sodium arsenite (E, F).   HSP30 was
detected indirectly with an anti-Xenopus HSP30 primary antibody and Alexa-488 secondary
antibody conjugate (green). Actin and nuclei were detected directly by staining with TRITC (red)
and DAPI (blue), respectively.  Cells were visualized using a Zeiss LSM 510 Meta laser confocal
microscope. The left column indicates HSP30 fluorescence, while the right column shows a
merged image of and HSP30, actin and DAPI fluorescence. A low magnification was used to
demonstrate the relative proportion of cells expressing HSP30 (A-B).  The same cells were then
imaged using a higher magnification (C-D). Treatment of A6 cells with 10 µM sodium arsenite
for 14 h 22°C resulted in the collapse of the actin cytoskeleton (arrow).   HSP30 accumulation
was observed throughout the entire cytoplasm (circle arrow) and is absent from the nucleus










Figure 30.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells treated with 100 µM cadmium chloride.  A6 cells were grown on glass coverslips in
L-15 media and were treated with 100 µM cadmium chloride for 14 h at 22°C (A-F).  Other A6
cells were pre-treated with 100 µM KNK437 before being treated with cadmium chloride (E-F).
HSP30 was detected indirectly with an anti-Xenopus HSP30 primary antibody and Alexa-488
secondary antibody conjugate (green). Actin and nuclei were detected directly by staining with
TRITC (red) and DAPI (blue), respectively.  Cells were visualized using a Zeiss LSM 510 Meta
laser confocal microscope.  The left column indicates HSP30 fluorescence, while the right
column shows a merged image of and HSP30, actin and DAPI fluorescence.  A low
magnification was used to demonstrate the relative proportion of cells expressing HSP30 (A-B).
The same cells were then imaged using a higher magnification (C-D).  Treatment of A6 with 100
µM cadmium chloride for 14 h at 22°C resulted in the accumulation of HSP30 in the cytoplasm,
particularly around the nucleus (arrow), however it was absent within the nucleus itself
(asterisk).  HSP30 is occasionally present in a punctate pattern (diamond arrow).  This treatment
both on its own and in conjunction with KNK437 resulted in the ruffling of the actin








Figure  31.  The effect of KNK437 on the intracellular accumulation of HSP30 in Xenopus
A6 cells treated with 1 µg/mL herbimycin A.  A6 cells were grown on glass coverslips in L-15
media and were treated with 1 µg/mL herbimycin A for 14 h at 22°C (A-F).  Other cells were
pre-treated with 100 µM KNK437 before being treated with herbimycin A.   HSP30 was detected
indirectly with an anti-Xenopus HSP30 primary antibody and Alexa-488 secondary antibody
conjugate (green). Actin and nuclei were detected directly by staining with TRITC (red) and
DAPI (blue), respectively.  Cells were visualized using a Zeiss LSM 510 Meta laser confocal
microscope.  The left column indicates HSP30 fluorescence, while the right column shows a
merged image of and HSP30, actin and DAPI fluorescence. A low magnification was used to
demonstrate the relative proportion of cells expressing HSP30 (A-B).  The same cells were then
imaged using a higher magnification (C-D).  Treatment of A6 cells with 1 µg/mL herbimycin A
for 14 h at 22°C resulted in the accumulation of HSP30 evenly throughout the cytoplasm









This study has shown, for the first time, that the heat shock factor inhibitor, KNK437,
inhibited the expression of chemical- induced hsp gene expression in a non-mammalian cell line;
Xenopus laevis A6 cells.  Initial studies demonstrated that treatment of A6 cells with sodium
arsenite, cadmium chloride or herbimycin A resulted in the accumulation of hsp30 mRNA as
well as HSP30 and HSP70 protein.  Previously, in our laboratory, it was reported that treatment
of Xenopus A6 cells with sodium arsenite induced the accumulation of hsp30, hsp70, hsp90 and
hsp110 mRNA as well as HSP30 and HSP110 protein (Darasch et al., 1988; Ali et al., 1996;
Gellalchew & Heikkila, 2005; Gauley & Heikkila, 2006).  Also, in Xenopus A6 cells, cadmium
chloride induced the accumulation of hsp70 and hsp110 mRNA, while herbimycin A induced the
expression of hsp30 and hsp70 genes (Briant et al., 1997; Gauley & Heikkila, 2006).  These
aforementioned chemical stressors have also been shown to induce hsp gene expression in
mammalian cells (Hegde et al., 1995; Conde et al., 1997; Gaubin et al., 2000, Kim et al., 2001).
The induction of hsp gene expression in Xenopus by these chemical stressors likely involves the
activation of heat shock factor (HSF) and binding to the heat shock element (HSE) as determined
for heat shock (Ovsenek & Heikkila, 1990).  It has been demonstrated that treatment of Xenopus
oocytes with sodium arsenite and cadmium chloride resulted in the specific binding of heat shock
factor 1 (HSF1) to heat shock HSE as determined with gel shift assays (Gordon et al., 1997).
Increased binding of HSF and HSE has also been shown in Schneider S2 cells when cells were
treated with herbimycin A (Duncan, 2005).  Although the exact pathways that lead to the
induction of hsps when A6 cells are exposed to sodium arsenite, cadmium chloride or
herbimycin A are unknown, the end result appears to be the induction of HSF1 which induces
the expression of hsp genes.
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KNK437 is a known inhibitor of HSF1 activity (Yokota et al., 2000).  The present study has
demonstrated that a 2 h pre-treatment with 100 µM KNK437 was sufficient to inhibit hsp30
mRNA accumulation in A6 cells and completely prevent HSP30 and HSP70 protein
accumulation in heat shocked A6 cells.  Also, immunocytochemistry revealed that there was no
detectable HSP30 accumulation in A6 cells that were pre-treated for 6 h with 100 µM KNK437
prior to heat shock.  This confirms previous studies in our laboratory showing that KNK437 was
capable of inhibiting heat-induced hsp30, hsp47 and hsp70 mRNA and HSP30 protein
accumulation in A6 cells (Manwell & Heikkila, 2007).  In mammalian cells, Yokota et al.,
(2000) found that KNK437 inhibited heat-induced HSP40, HSP70 and HSP105 accumulation.
Also, in A-172 human squamous carcinoma cells and A549 human lung adenocarcinoma cells,
KNK437 inhibited the heat shock induction of HSP27 and HSP72 (Ohnishi et al. 2004).  Finally,
KNK437 inhibited heat induced HSP27 accumulation in vivo in transplantable murine tumours in
C3H/He mice (Koishi et al., 2001).
While the inhibition of heat-induced hsp gene expression by KNK437 has been reported in
the literature, the inhibition of chemical stressor-induced hsp gene expression has not.  In a
single report, treatment of human COLO 320DM cells with KNK437 inhibited sodium arsenite-
induced acquisition of thermotolerance (Yokota et al., 2000).  However the effect of this agent
on hsp gene expression was not demonstrated.  In the present study, a 2 h pre-treatment of A6
cells with 100 µM KNK437 prior to a 20 µM exposure of sodium arsenite inhibited hsp30
mRNA accumulation by 51% after 12 h and HSP30 protein accumulation by 59 % after 24 h.
Also, KNK437 completely inhibited HSP70 accumulation after 24 h of sodium arsenite
treatment. Immunocytochemistry revealed that A6 cells treated with 10 µM sodium arsenite
resulted in HSP30 accumulation in the cytoplasm which was inhibited by KNK437 in
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approximately 97-100% of the cells.  Since sodium arsenite-induced expression of hsp genes
involves the activation of Xenopus HSF1 (Gordon et al., 1997), it is likely that KNK437 is
targeting this transcription factor.
In the present study, exposure of A6 cells to sodium arsenite caused a disruption in the actin
cytoskeleton.  Also in mammalian systems, sodium arsenite treatment of H9C2 myoblasts altered
focal adhesion structure and function (Yancy et al., 2005).  Since focal adhesions consist of
bundles of actin filaments and several adhesion-proteins, which attach the cytoskeleton to the
extracellular matrix (Jockusch at al., 1995), this may explain why Xenopus A6 cells treated at
higher concentrations of sodium arsenite, displayed a rounded morphology.  HSPs have also
been implicated in the protection of focal adhesion kinases (Mao et al., 2003).
In the present study, a 2 h pre-treatment with KNK437 was sufficient to inhibit cadmium
chloride-induced hsp30 mRNA by 33% at 12 h and by 90% after a 24 h treatment.  At the protein
level, both HSP30 and HSP70 were markedly inhibited by KNK437.  Immunocytochemistry
revealed that treatment of A6 cells with cadmium chloride resulted in HSP30 accumulation in a
punctate pattern, particularly in the perinuclear region.  This accumulation pattern of HSP30
accumulation was inhibited in 98-100% of the cells by KNK437.  As mentioned previously, the
effect of KNK437 on cadmium-induced hsp30 gene expression in A6 cells is likely the inhibition
of HSF activity.  Previous studies have shown that within cells, cadmium induced the
accumulation of denatured or abnormal proteins by substituting for zinc or reacting with vicinal
thiol groups in proteins (Waisberg et al., 2003).  An accumulation of denatured protein is a
signal for HSF activation.
Finally, this study revealed that a 2 h pre-treatment of A6 cells with 100 µM KNK437
inhibited hsp30 mRNA, HSP30 and HSP70 accumulation induced by herbimycin A.
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Herbimycin A, a benzoquinoid ansamycin antibiotic, has been shown to act as a tyrosine kinase
inhibitor and an inducer of hsp gene expression (Hegde et al., 1995).  While the mechanism of
herbimycin A induction of hsp gene expression is not known, it is thought to bypass stress
regulatory pathways in its activation of HSF.  The present study has shown that KNK437 can
inhibit hsp gene expression induced by pharmacological means.
Interesting differences were detected between heat- and chemically-inducible HSP30
localization in A6 cells.  Treatment of A6 cells with a 33°C heat shock, sodium arsenite,
cadmium chloride or herbimycin A resulted in HSP30 accumulation primarily in the cytoplasm.
However, heat shock treatment of A6 cells at 35°C resulted in enriched HSP30 accumulation in
the nucleus.  At this time, it is not known how HSP30 enters the nucleus since it has no known
nuclear localization sequence.  Furthermore, it was previously shown in our laboratory that
Xenopus HSP30C forms high molecular weight multimeric structures in vivo (Ohan et al., 1998).
Since proteins without a nuclear localization signal can only diffuse through nuclear pores if they
are smaller than 40 kDa (Breeuwer & Goldfarb, 1990), it is possible that HSP30 may be assisted
by a protein that possesses one.  Interestingly, HSP70 and HSC70, have been shown to play an
essential role in the transport of proteins to the nucleus (Shi & Thomas, 1992).  Since the HSP30
multimeric complex contains HSP70 (Ohan et al., 1998), it is possible that this molecular
chaperone is involved in transporting HSP30 into the nucleus.
Although KNK437 inhibited  hsp30 mRNA and HSP30 accumulation induced by all of the
chemical stressors used, the ability of KNK437 to inhibit hsp gene expression differed depending
on the type of stressor employed.  Herbimycin A, for example, induced a hsp response that was
weaker when compared to sodium arsenite or cadmium chloride.  This may result from the
relative toxicity of sodium arsenite or cadmium chloride to A6 cells when compared to that of
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herbimycin A.  As herbimycin A is less toxic to the cells and it circumvents the stress regulatory
pathway (Hegde et al., 1995), it is possible that there is a reduced activation of HSF1 compared
to sodium arsenite or cadmium chloride.  Also in comparison to heat shock, it was previously
shown in A6 cells that herbimycin A resulted in a weaker accumulation of hsp30 and hsp70
mRNA (Briant et al., 1997).
In summary, the present study has shown that KNK437 is an inhibitor of hsp gene
expression induced not only by heat shock but also by sodium arsenite, cadmium chloride or
herbimycin A.  In future studies, it would be beneficial to perform a gel shift assay to verify that
KNK437 affects the binding of HSF1 to HSE in Xenopus A6 cells.  Previously, it was
demonstrated that KNK437 inhibited the heat shock-induced acquisition of thermotolerance in
A6 cells (Manwell and Heikkila, 2007).  Thus it would be interesting to determine whether
KNK437 is able to inhibit the acquisition of thermotolerance or stress resistance in A6 cells
induced by the various chemical stressors used in the present study.
To date, studies employing KNK437 to inhibit hsp gene expression have only been
carried out in cultured cells.  It would be interesting to examine its effect in a developmental
system.  Previous studies in our laboratory have shown that hsp30 mRNA was present
constitutively in the cement gland of early and midtailbud embryos and that HSP30 protein was
not present until the early tadpole stage.  In heat shocked embryos, hsp30 mRNA and HSP30
protein accumulation was enriched in the cement gland, somitic region, lens placode and
proctodeum at the early to midtailbud stages.  It is likely that HSF1 was involved in the induction
of heat induced hsp30 gene expression (Heikkila et al., 2003).  However, it is not known whether
HSF1 is involved in the constitutive accumulation of hsp30 mRNA in the cement gland of
Xenopus embryos.  Thus, additional experiments could examine the effect of inhibiting HSF1 by
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KNK437 on the viability, morphology, and pattern of hsp gene expression in control and heat
shocked Xenopus laevis embryos during early development.
The discovery of KNK437 as an HSF inhibitor has proved to be a valuable tool in the
optimization of cell death in tumour cells by combining radiation with thermal therapy (Yokota
et al., 2000; Sakurai et al., 2005).  While these experiments have been beneficial to the field of
cancer research, KNK437 has been used very little as a tool for examining the role of HSPs in
certain cellular or developmental processes.  Also, since KNK437 is a universal inhibitor of
HSF1, it would be useful for research examining hsp gene expression in non-model systems.
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